Selected Grants
The North Carolina Congenital Heart Disease Surveillance Network
Public ServicePrincipal Investigator · Awarded by Centers for Disease Control and Prevention · 2024 - 2029Determining the genetic and social determinants of heart failure and mortality in patients with congenital heart disease
ResearchCo Investigator · Awarded by National Institutes of Health · 2023 - 2028Stimulating Access to Research in Residency (StARR) - NHLBI
Inst. Training Prgm or CMEPreceptor · Awarded by National Heart, Lung, and Blood Institute · 2018 - 2028UNC-Duke Collaborative Clinical Pharmacology Postdoctoral Training Program
Inst. Training Prgm or CMEMentor · Awarded by University of North Carolina - Chapel Hill · 2016 - 2026Duke-UNC Collaborative Pediatric Clinical Pharmacology Postdoctoral Training Program
Inst. Training Prgm or CMEPreceptor · Awarded by National Institutes of Health · 2021 - 2026The North Carolina Congenital Heart Disease Surveillance Network
Public ServicePrincipal Investigator · Awarded by Centers for Disease Control and Prevention · 2024 - 2029Determining the genetic and social determinants of heart failure and mortality in patients with congenital heart disease
ResearchCo Investigator · Awarded by National Institutes of Health · 2023 - 2028Stimulating Access to Research in Residency (StARR) - NHLBI
Inst. Training Prgm or CMEPreceptor · Awarded by National Heart, Lung, and Blood Institute · 2018 - 2028UNC-Duke Collaborative Clinical Pharmacology Postdoctoral Training Program
Inst. Training Prgm or CMEMentor · Awarded by University of North Carolina - Chapel Hill · 2016 - 2026Duke-UNC Collaborative Pediatric Clinical Pharmacology Postdoctoral Training Program
Inst. Training Prgm or CMEPreceptor · Awarded by National Institutes of Health · 2021 - 2026Duke Center for Advancement of Child Health (CAtCH).
Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 2021 - 2026Digoxin Pharmacodynamics in Infants with Heart Failure due to Single Ventricle Congenital Heart Disease
ResearchCo Investigator · Awarded by National Institutes of Health · 2022 - 2026Pediatric Heart Network-SVRIII
Clinical TrialPrincipal Investigator · Awarded by New England Research Institutes, Inc. · 2017 - 2025The North Carolina Congenital Heart Disease Surveillance Network
Public ServicePrincipal Investigator · Awarded by Centers for Disease Control and Prevention · 2019 - 2025Safety of Sildenafil in Premature Infants with Severe Bronchopulmonary Dysplasia
ResearchInvestigator · Awarded by National Institutes of Health · 2019 - 2025The Colin's Kids Pediatric Cardiology Research Funds
ResearchPrincipal Investigator · Awarded by Colin's Kids, Inc. · 2019 - 2025Postdoctoral Training in Cardiovascular Clinical Research
Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 2003 - 2025Low-Interventional Cohort Study of Myocarditis/Pericarditis Associated With COMIRNATY in Persons Less Than 21 Years of Age.
Clinical TrialPrincipal Investigator · Awarded by Pfizer, Inc. · 2023 - 2024Duke CTSA (TL1) Year 5
Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 2018 - 2024Unified Program for Therapeutics in Children
Inst. Training Prgm or CMEPreceptor · Awarded by National Institutes of Health · 2019 - 2024Duke CTSA (UL1)
ResearchCo-Principal Investigator · Awarded by National Institutes of Health · 2018 - 2024Bridging the Gap to Enhance Clinical Research Program (BIGGER)
Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 2016 - 2023NCDHHS Sickle Cell Data Collection Program in North Carolina Year 3
Public ServiceCo Investigator · Awarded by NC Department of Health and Human Services · 2022 - 2023Pediatric Heart Network CHILD-DS Study
Clinical TrialPrincipal Investigator · Awarded by New England Research Institutes, Inc. · 2023 - 2023Sickle Cell Data Collection Program in North Carolina
Public ServiceCo Investigator · Awarded by NC Department of Health and Human Services · 2021 - 2022Leveraging registry resources for efficient and cost effective clinical trials
Clinical TrialPrincipal Investigator · Awarded by National Institutes of Health · 2016 - 2022UNC-Duke Collaborative Clinical Pharmacology Postdoctoral Training Program
Inst. Training Prgm or CMEMentor · Awarded by University of North Carolina - Chapel Hill · 2020 - 2021Grant- NU05DD004933 (Duke as a site #05)
Clinical TrialPrincipal Investigator · Awarded by Centers for Disease Control and Prevention · 2016 - 2020North Carolina Congenital Heart Defects Surveillance Network
ResearchPrincipal Investigator · Awarded by Centers for Disease Control and Prevention · 2015 - 2020Echocardiogram to Diagnose Pulmonary Hypertension in Premature Infants
ResearchCo Investigator · Awarded by University of North Carolina - Chapel Hill · 2015 - 2019IMPROVING PATIENT AND FAMILY HEALTH USING FAMILY-CENTERED OUTCOMES AND SHARED DECISION MAKING
ResearchPrincipal Investigator · Awarded by University of Utah · 2018 - 2019Duke CTSA (KL2)
ResearchCo-Principal Investigator · Awarded by National Institutes of Health · 2013 - 2018Duke CTSA (TL1)
Inst. Training Prgm or CMECo-Principal Investigator · Awarded by National Institutes of Health · 2013 - 2018Duke Research Training Program for Pediatricians
Inst. Training Prgm or CMETraining Faculty · Awarded by National Institutes of Health · 2002 - 2018Duke CTSA (UL1)
ResearchCo-Principal Investigator · Awarded by National Institutes of Health · 2013 - 2018Safety, Pharmacokinetics (PK) and Hemodynamic Effects of Ambrisentan in Children with Single Ventricle Heart Defects.
FellowshipMentor · Awarded by Gilead Sciences, Inc. · 2015 - 2018Evaluation of endothelial function in single ventricle patients receiving Ambrisentan after surgery.
ResearchPrincipal Investigator · Awarded by Thrasher Research Fund · 2015 - 2017Pediatric Heart Network
Clinical TrialPrincipal Investigator · Awarded by New England Research Institutes, Inc. · 2015 - 2017Pediatric Heart Network
Clinical TrialPrincipal Investigator · Awarded by New England Research Institutes, Inc. · 2011 - 2017Pediatric Heart Netwrok - Auxillary Site
Clinical TrialPrincipal Investigator · Awarded by New England Research Institutes, Inc. · 2015 - 2016The Duke Multidisciplinary Training Program in Pediatric Lung Disease
Inst. Training Prgm or CMEFaculty Member · Awarded by National Institutes of Health · 2010 - 2016Molecular Mechanisms of Thoracic Aortic Aneurysms
FellowshipPrincipal Investigator · Awarded by Cincinnati Children's Hospital Medical Center · 2014 - 2016UNC-Duke Collaborative Clinical Pharmacology Postdoctoral Training Program
Inst. Training Prgm or CMEMentor · Awarded by University of North Carolina - Chapel Hill · 2011 - 2016Pediatric Heart Netwrok
Clinical TrialPrincipal Investigator · Awarded by New England Research Institutes, Inc. · 2014 - 2015Multidisciplinary Neonatal Training Grant
Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 2010 - 2015Institutional Training Grant in Pediatric Cardiology
Inst. Training Prgm or CMEPrincipal Investigator · Awarded by National Institutes of Health · 2009 - 2015Career Development in Outcomes Assessment in Congenital Heart Surgery
ResearchMentor · Awarded by National Institutes of Health · 2010 - 2014CTSA UL
ResearchDirector · Awarded by National Institutes of Health · 2006 - 2012Comparative Effectiveness of Medications Used in Congenital Heart Surgery
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2009 - 2012Prevention of Cardiovascular Complications of Pediatric SLE
Clinical TrialCo Investigator · Awarded by National Institutes of Health · 2002 - 2011Pediatric Heart Network North Carolina Consortium
Clinical TrialPrincipal Investigator · Awarded by National Institutes of Health · 2001 - 2011North Carolina Collaborative PPRU Network
Clinical TrialCo Investigator · Awarded by National Institutes of Health · 2004 - 2010Best Pharmaceutical for Children Act (BPCA): Use of Meropenem in Infants
Clinical TrialCo Investigator · Awarded by National Institutes of Health · 2007 - 2010NIH National Research Service Award Institutional Research Training Grant (T32) Duke Pediatric Cardiology
Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 2004 - 2009External Relationships
- Alnylam Pharmaceutical, Inc.
- Cytokinetics, Inc.
- Janssen Pharmaceuticals (Johnson & Johnson)
- Lumanity
- W. L. Gore & Associates, Inc.
This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.